These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36922513)

  • 1. A rare human variant that disrupts GPR10 signalling causes weight gain in mice.
    Talbot F; Feetham CH; Mokrosiński J; Lawler K; Keogh JM; Henning E; Mendes de Oliveira E; Ayinampudi V; Saeed S; Bonnefond A; Arslan M; Yeo GSH; Froguel P; Bechtold DA; Adamson A; Humphreys N; Barroso I; Luckman SM; Farooqi IS
    Nat Commun; 2023 Mar; 14(1):1450. PubMed ID: 36922513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice.
    Gu W; Geddes BJ; Zhang C; Foley KP; Stricker-Krongrad A
    J Mol Neurosci; 2004; 22(1-2):93-103. PubMed ID: 14742914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR10 deficiency in mice results in altered energy expenditure and obesity.
    Bjursell M; Lennerås M; Göransson M; Elmgren A; Bohlooly-Y M
    Biochem Biophys Res Commun; 2007 Nov; 363(3):633-8. PubMed ID: 17904108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR10 gene deletion in mice increases basal neuronal activity, disturbs insulin sensitivity and alters lipid homeostasis.
    Pražienková V; Funda J; Pirník Z; Karnošová A; Hrubá L; Kořínková L; Neprašová B; Janovská P; Benzce M; Kadlecová M; Blahoš J; Kopecký J; Železná B; Kuneš J; Bardová K; Maletínská L
    Gene; 2021 Mar; 774():145427. PubMed ID: 33450349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect.
    Alexopoulou F; Bech EM; Pedersen SL; Thorbek DD; Leurs U; Rudkjær LCB; Fosgerau K; Hansen HH; Vrang N; Jelsing J; Elster L
    Sci Rep; 2022 Feb; 12(1):1696. PubMed ID: 35105898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.
    Varghese BV; Koohestani F; McWilliams M; Colvin A; Gunewardena S; Kinsey WH; Nowak RA; Nothnick WB; Chennathukuzhi VM
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2187-92. PubMed ID: 23284171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutated G-protein-coupled receptor GPR10 is responsible for the hyperphagia/dyslipidaemia/obesity locus of Dmo1 in the OLETF rat.
    Watanabe TK; Suzuki M; Yamasaki Y; Okuno S; Hishigaki H; Ono T; Oga K; Mizoguchi-Miyakita A; Tsuji A; Kanemoto N; Wakitani S; Takagi T; Nakamura Y; Tanigami A
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):355-66. PubMed ID: 15854142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study.
    Karnošová A; Strnadová V; Holá L; Železná B; Kuneš J; Maletínská L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphisms in GPR10, the gene encoding the prolactin-releasing peptide receptor with blood pressure, but not obesity, in a U.K. Caucasian population.
    Bhattacharyya S; Luan J; Challis B; Schmitz C; Clarkson P; Franks PW; Middelberg R; Keogh J; Farooqi IS; Montague C; Brennand J; Wareham NJ; O'Rahilly S
    Diabetes; 2003 May; 52(5):1296-9. PubMed ID: 12716769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models for V103I and I251L gain of function variants of the human MC4R display decreased adiposity but are not protected against a hypercaloric diet.
    Rojo D; McCarthy C; Raingo J; Rubinstein M
    Mol Metab; 2020 Dec; 42():101077. PubMed ID: 32916307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10.
    Laurent P; Becker JA; Valverde O; Ledent C; de Kerchove d'Exaerde A; Schiffmann SN; Maldonado R; Vassart G; Parmentier M
    Nat Neurosci; 2005 Dec; 8(12):1735-41. PubMed ID: 16299503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor.
    Langmead CJ; Szekeres PG; Chambers JK; Ratcliffe SJ; Jones DN; Hirst WD; Price GW; Herdon HJ
    Br J Pharmacol; 2000 Oct; 131(4):683-8. PubMed ID: 11030716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.
    Pražienková V; Popelová A; Kuneš J; Maletínská L
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTCP deficiency in mice protects against obesity and hepatosteatosis.
    Donkers JM; Kooijman S; Slijepcevic D; Kunst RF; Roscam Abbing RL; Haazen L; de Waart DR; Levels JH; Schoonjans K; Rensen PC; Oude Elferink RP; van de Graaf SF
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31237863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing of 640,000 exomes identifies
    Akbari P; Gilani A; Sosina O; Kosmicki JA; Khrimian L; Fang YY; Persaud T; Garcia V; Sun D; Li A; Mbatchou J; Locke AE; Benner C; Verweij N; Lin N; Hossain S; Agostinucci K; Pascale JV; Dirice E; Dunn M; ; ; Kraus WE; Shah SH; Chen YI; Rotter JI; Rader DJ; Melander O; Still CD; Mirshahi T; Carey DJ; Berumen-Campos J; Kuri-Morales P; Alegre-Díaz J; Torres JM; Emberson JR; Collins R; Balasubramanian S; Hawes A; Jones M; Zambrowicz B; Murphy AJ; Paulding C; Coppola G; Overton JD; Reid JG; Shuldiner AR; Cantor M; Kang HM; Abecasis GR; Karalis K; Economides AN; Marchini J; Yancopoulos GD; Sleeman MW; Altarejos J; Della Gatta G; Tapia-Conyer R; Schwartzman ML; Baras A; Ferreira MAR; Lotta LA
    Science; 2021 Jul; 373(6550):. PubMed ID: 34210852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic bile acid-TGR5 signaling protects from obesity.
    Castellanos-Jankiewicz A; Guzmán-Quevedo O; Fénelon VS; Zizzari P; Quarta C; Bellocchio L; Tailleux A; Charton J; Fernandois D; Henricsson M; Piveteau C; Simon V; Allard C; Quemener S; Guinot V; Hennuyer N; Perino A; Duveau A; Maitre M; Leste-Lasserre T; Clark S; Dupuy N; Cannich A; Gonzales D; Deprez B; Mithieux G; Dombrowicz D; Bäckhed F; Prevot V; Marsicano G; Staels B; Schoonjans K; Cota D
    Cell Metab; 2021 Jul; 33(7):1483-1492.e10. PubMed ID: 33887197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of leptin receptors in vagal afferent neurons disrupts estrogen signaling, body weight, food intake and hormonal controls of feeding in female mice.
    Huang KP; Ronveaux CC; de Lartigue G; Geary N; Asarian L; Raybould HE
    Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E568-E577. PubMed ID: 30753113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between physical activity and blood pressure is modified by variants in the G-protein coupled receptor 10.
    Franks PW; Bhattacharyya S; Luan J; Montague C; Brennand J; Challis B; Brage S; Ekelund U; Middelberg RP; O'Rahilly S; Wareham NJ
    Hypertension; 2004 Feb; 43(2):224-8. PubMed ID: 14691196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
    Schuchard J; Winkler M; Stölting I; Schuster F; Vogt FM; Barkhausen J; Thorns C; Santos RA; Bader M; Raasch W
    Br J Pharmacol; 2015 Aug; 172(15):3764-78. PubMed ID: 25906670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of nuclear receptor SHP in adipose tissues affects diet-induced obesity and adaptive thermogenesis.
    Tabbi-Anneni I; Cooksey R; Gunda V; Liu S; Mueller A; Song G; McClain DA; Wang L
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E961-70. PubMed ID: 20124506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.